CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
Revenue	$ 131,612	$ 119,497
Expenses:
Cost of sales	1,463	2,151
Research, development and patent	200,759	214,215
Selling, general and administrative	76,250	52,644
Total operating expenses	278,472	269,010
Loss from operations	(146,860)	(149,513)
Other income (expense):
Investment income	24,667	26,285
Interest expense	(4,108)	(4,151)
Interest expense related to sale of future royalties	(18,822)	(17,959)
Gain (loss) on investments	(2,164)	2,333
Other income	465	277
Loss before income tax expense	(146,822)	(142,728)
Income tax expense	(116)	(75)
Net loss	$ (146,938)	$ (142,803)
Basic net loss per share (in dollars per share)	$ (0.93)	$ (0.98)
Diluted net loss per share (in dollars per share)	$ (0.93)	$ (0.98)
Shares used in computing basic net loss per share (in shares)	158,735	145,538
Shares used in computing diluted net loss per share (in shares)	158,735	145,538
Commercial Revenue [Member]
Revenue:
Revenue	$ 76,168	$ 59,593
Product Sales, Net [Member]
Revenue:
Revenue	6,287	0
Royalty Revenue [Member]
Revenue:
Revenue	64,166	49,385
Other Commercial Revenue [Member]
Revenue:
Revenue	5,715	10,208
Research and Development Revenue [Member]
Revenue:
Revenue	55,444	59,904
Collaborative Agreement Revenue [Member]
Revenue:
Revenue	45,031	49,345
WAINUA Joint Development Revenue [Member]
Revenue:
Revenue	$ 10,413	$ 10,559